The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
An endurance runner has set a new record by running and climbing 24 mountains over a distance of 56 miles, in 24 hours.
It is up to the Supreme Court judges to decide whether the legal dispute over Brexit is, perhaps, a red herring for something else.
Urdu, Chinese, Arabic and Polish make up the majority of languages after English.